Jpmorgan Chase & CO Ac Immune Sa Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Ac Immune Sa stock. As of the latest transaction made, Jpmorgan Chase & CO holds 7,107 shares of ACIU stock, worth $22,955. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,107
Previous 8,424 15.63%
Holding current value
$22,955
Previous $22,000 40.91%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$1.87 - $2.98 $2,462 - $3,924
-1,317 Reduced 15.63%
7,107 $13,000
Q4 2024

Feb 12, 2025
SELL
$2.67 - $3.75 $6,066 - $8,520
-2,272 Reduced 21.24%
8,424 $22,000
Q3 2024

Dec 26, 2024
SELL
$2.99 - $4.2 $1,961 - $2,755
-656 Reduced 5.78%
10,696 $40,000
Q3 2024

Nov 08, 2024
SELL
$2.99 - $4.2 $1,961 - $2,755
-656 Reduced 5.78%
10,696 $40,000
Q2 2024

Dec 26, 2024
BUY
$2.29 - $4.87 $1,502 - $3,194
656 Added 6.13%
11,352 $45,000
Q2 2024

Aug 12, 2024
SELL
$2.29 - $4.87 $24,647 - $52,415
-10,763 Reduced 48.67%
11,352 $45,000
Q1 2024

Dec 26, 2024
BUY
$2.66 - $4.87 $30,374 - $55,610
11,419 Added 106.76%
22,115 $65,000
Q1 2024

May 10, 2024
BUY
$2.66 - $4.87 $47,446 - $86,866
17,837 Added 416.95%
22,115 $65,000
Q4 2023

Dec 26, 2024
SELL
$2.46 - $5.0 $15,788 - $32,090
-6,418 Reduced 60.0%
4,278 $21,000
Q4 2023

Feb 12, 2024
BUY
$2.46 - $5.0 $7,571 - $15,390
3,078 Added 256.5%
4,278 $21,000
Q3 2023

Nov 14, 2023
SELL
$2.77 - $3.38 $4,243 - $5,178
-1,532 Reduced 56.08%
1,200 $3,000
Q4 2022

Feb 13, 2023
SELL
$1.72 - $3.12 $4,367 - $7,921
-2,539 Reduced 48.17%
2,732 $6,000
Q3 2022

Nov 14, 2022
BUY
$2.4 - $3.64 $4,221 - $6,402
1,759 Added 50.09%
5,271 $17,000
Q2 2022

Aug 11, 2022
SELL
$2.35 - $4.47 $13,907 - $26,453
-5,918 Reduced 62.76%
3,512 $13,000
Q1 2022

May 11, 2022
BUY
$3.5 - $5.16 $8,393 - $12,373
2,398 Added 34.1%
9,430 $38,000
Q4 2021

Feb 10, 2022
SELL
$4.83 - $7.56 $43,948 - $68,788
-9,099 Reduced 56.41%
7,032 $35,000
Q3 2021

Nov 12, 2021
BUY
$6.2 - $8.34 $100,012 - $134,532
16,131 New
16,131 $109,000

Others Institutions Holding ACIU

# of Institutions
45
Shares Held
26.9M
Call Options Held
0
Put Options Held
28.5K
View Full List

About AC Immune SA

ACIU Quotes by TradingView
  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $269M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email